– An Exploratory Study of Itolizumab on the Preservation of Beta Cell Function in Adults with Recent-Onset Type 1 Diabetes. J Clin Med. 2022 Mar 24;11(7):1789.
– Potency, toxicity and protection evaluation of PastoCoAd candidate vaccines: Novel preclinical mix and match rAd5 S, rAd5 RBD-N and SOBERANA dimeric-RBD protein. Vaccine. 2022 May 3;40(20):2856-2868.
– Transient production of receptor-binding domain of SARS-CoV-2 in Nicotiana benthamiana plants induces specific antibodies in immunized mice. Mol Biol Rep. 2022 May 8;1-11.
– Assessment of changes in immune status linked to COVID-19 convalescent and its clinical severity in patients and uninfected exposed relatives. Immunobiology. 2022 Apr 12;227(3):152216.
– Safety, tolerability, and immunogenicity of a SARS-CoV-2 recombinant spike RBD protein vaccine: A randomised, double-blind, placebo-controlled, phase 1-2 clinical trial (ABDALA Study). EClinicalMedicine. 2022 Apr;46:101383.
En la sección: Autores cubanos en revistas extranjeras, COVID-19, Infectología, Inflamación, Vacunología. Publicado en: . 
